कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
TH | टोरंटो | CAD | रियल टाइम | |
THTX | NASDAQ | USD | रियल टाइम | |
TH | CBOE कनाडा | CAD | रियल टाइम |
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Roger Guillemin | - | - | Member of the Scientific Advisory Board |
David Clemmons | - | - | Member of the Scientific Advisory Board |
Peter Reiss | - | - | Member of the Scientific Advisory Board |
Steven Grinspoon | - | - | Member of the Scientific Advisory Board |
Julian Falutz | - | - | Member of the Scientific Advisory Board |
George R. Merriam | - | - | Member of the Scientific Advisory Board |
Dawn A. Svoronos | 70 | 2013 | Independent Chair of the Board |
Gerald A. Lacoste | 79 | 2006 | Independent Director |
Paul Lévesque | 59 | 2020 | President, CEO & Director |
Dale MacCandlish-Weil | 67 | 2017 | Independent Director |
Joseph P. Arena | 68 | 2021 | Independent Director |
Andrew T. Molson | 55 | 2020 | Independent Director |
Frank A. Holler | 67 | 2021 | Independent Director |
Jordan Zwick | 37 | 2024 | Independent Director |
Elina Tea | 47 | 2024 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है